These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27317883)

  • 1. Reactivation of mutant p53: Constraints on mechanism highlighted by principal component analysis of the DNA binding domain.
    Ouaray Z; ElSawy KM; Lane DP; Essex JW; Verma C
    Proteins; 2016 Oct; 84(10):1443-61. PubMed ID: 27317883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.
    D'Abramo M; Bešker N; Desideri A; Levine AJ; Melino G; Chillemi G
    Oncogene; 2016 Jun; 35(25):3272-81. PubMed ID: 26477317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of the DNA-binding-induced loop L1 conformational switch in an engineered human p53 protein.
    Emamzadah S; Tropia L; Vincenti I; Falquet B; Halazonetis TD
    J Mol Biol; 2014 Feb; 426(4):936-44. PubMed ID: 24374182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
    Lubin DJ; Butler JS; Loh SN
    J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R248Q mutation--Beyond p53-DNA binding.
    Ng JW; Lama D; Lukman S; Lane DP; Verma CS; Sim AY
    Proteins; 2015 Dec; 83(12):2240-50. PubMed ID: 26442703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.
    Butler JS; Loh SN
    Biochemistry; 2003 Mar; 42(8):2396-403. PubMed ID: 12600206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimerization of the core domain of the p53 family: a computational study.
    Madhumalar A; Jun LH; Lane DP; Verma CS
    Cell Cycle; 2009 Jan; 8(1):137-48. PubMed ID: 19106606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain.
    Wright JD; Noskov SY; Lim C
    Nucleic Acids Res; 2002 Apr; 30(7):1563-74. PubMed ID: 11917017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating DNA Binding and Conformational Variation in Temperature Sensitive p53 Cancer Mutants Using QM-MM Simulations.
    Koulgi S; Achalere A; Sonavane U; Joshi R
    PLoS One; 2015; 10(11):e0143065. PubMed ID: 26579714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics.
    Lukman S; Lane DP; Verma CS
    PLoS One; 2013; 8(11):e80221. PubMed ID: 24324553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Cho Y; Gorina S; Jeffrey PD; Pavletich NP
    Science; 1994 Jul; 265(5170):346-55. PubMed ID: 8023157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of AmtR, the global nitrogen regulator of Corynebacterium glutamicum, in free and DNA-bound forms.
    Palanca C; Rubio V
    FEBS J; 2016 Mar; 283(6):1039-59. PubMed ID: 26744254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity.
    Petty TJ; Emamzadah S; Costantino L; Petkova I; Stavridi ES; Saven JG; Vauthey E; Halazonetis TD
    EMBO J; 2011 Jun; 30(11):2167-76. PubMed ID: 21522129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
    Pavletich NP; Chambers KA; Pabo CO
    Genes Dev; 1993 Dec; 7(12B):2556-64. PubMed ID: 8276238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.
    Laptenko O; Tong DR; Manfredi J; Prives C
    Trends Biochem Sci; 2016 Dec; 41(12):1022-1034. PubMed ID: 27669647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raman Evidence of p53-DBD Disorder Decrease upon Interaction with the Anticancer Protein Azurin.
    Signorelli S; Cannistraro S; Bizzarri AR
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
    Fadda E; Nixon MG
    Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent and active p53 are identical in conformation.
    Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
    Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.
    Krois AS; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11302-E11310. PubMed ID: 30420502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.